News | December 09, 2023
Fire accident at Parmax Pharma’s plant
There has been no loss or injury to human life
There has been no loss or injury to human life
NATCO temporarily shut down the operations due to cyclone with flooding/water logging of the factory premises
The CAPSUL solution enables optimal process performance for production of premier quality PCL grades at competitive rates
The product is expected to be launched in FY25
First-ever brain chemistry database will allow clinicians to quickly infer brain biomarker data to support the diagnostic process in conditions such as Alzheimer's Disease
Decision on EU marketing authorisation expected for momelotinib by early 2024
OCEANIC-AF is one trial which evaluates asundexian versus apixaban in patients with atrial fibrillation at risk for stroke within the overall OCEANIC phase III program
Extraintestinal pathogenic E. coli (ExPEC) has been identified as the leading bacterial cause of sepsis
Dr. Lal Path Labs has reported total income of Rs. 619.4 crores during the period ended September 30, 2023
Zydus will pay an upfront consideration of GBP 68 million and yearly earn-outs until 2026
Subscribe To Our Newsletter & Stay Updated
